Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Fruhwald, FM; Kjellström, B; Perthold, W; Wonisch, M; Maier, R; Klein, W.
Hemodynamic observations in two pulmonary hypertensive patients changing treatment from inhaled iloprost to the oral endothelin-antagonist bosentan.
J HEART LUNG TRANSPLANT. 2005; 24(5): 631-634. Doi: 10.1016/j.healun.2004.03.001 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz
Fruhwald Friedrich
Co-authors Med Uni Graz
Maier Robert
Wonisch Manfred
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Two female patients with pulmonary arterial hypertension and a permanently implanted hemodynamic monitor changed treatment from inhaled iloprost to oral bosentan. The hemodynamic changes were seen very early after the first dose of bosentan and there was no need to re-establish inhaled iloprost.
Find related publications in this database (using NLM MeSH Indexing)
Administration, Inhalation -
Administration, Oral -
Adult -
Antihypertensive Agents - administration and dosage
Female - administration and dosage
Hemodynamic Processes - drug effects
Humans - drug effects
Hypertension, Pulmonary - drug therapy
Iloprost - administration and dosage
Middle Aged - administration and dosage
Monitoring, Ambulatory - instrumentation
Prostheses and Implants - instrumentation
Receptors, Endothelin - antagonists and inhibitors
Sulfonamides - administration and dosage

© Med Uni GrazImprint